Mooren's Ulcer in a Cornea Referral Practice in Korea

被引:4
|
作者
Kim, Dong Hyun [1 ]
Kim, Mee Kum [1 ,2 ]
Wee, Won Ryang [1 ,2 ]
Oh, Joo Youn [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Ophthalmol, 101 Daehak Ro, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Lab Ocular Regenerat Med & Immunol, Seoul Artificial Eye Ctr, Biomed Res Inst, Seoul 110744, South Korea
关键词
perforation; Korean; cornea; Age; Mooren's ulcer; PENETRATING KERATOPLASTY; CLINICAL CHARACTERISTICS; SOUTH-INDIA;
D O I
10.3109/09273948.2014.926938
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the clinical characteristics of patients with Mooren's ulcer in the Korean population, and to identify the risk factors that affect the therapeutic outcome. Methods: We reviewed the medical records of 33 eyes of 24 Korean patients who were referred to a cornea clinic and clinically diagnosed with Mooren's ulcer. Results: Despite intensive immunosuppression, corneal perforation occurred in 16 of 24 (66.7%) patients, which required tectonic graft. Age was significantly correlated with corneal perforation development: the age was 52.5 +/- 21.8 years in patients with perforation and 70.2 +/- 6.1 years in those without perforation (p = 0.036). Also, all 8 patients who were 55 years and younger had corneal perforation, while 8 of 16 patients older than 55 years developed perforation (p = 0.022). Other factors had no significant correlation with the occurrence of perforation. Conclusions: Young patients with Mooren's ulcer should be treated and carefully followed for high possibility of corneal perforation.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 50 条
  • [31] A Study of Clinical Characteristics and Treatment of Mooren's Ulcer
    Hanping Xie
    眼科学报, 1998, (03) : 164 - 169
  • [32] The involvement of multipotential progenitor cells in Mooren's ulcer
    Lee, IG
    Ye, J
    Kim, JC
    YONSEI MEDICAL JOURNAL, 2005, 46 (03) : 353 - 358
  • [33] Clinical characteristics of Mooren's ulcer in south India
    Srinivasan, Muthaiah
    Zegans, Michael E.
    Zelefsky, Joseph R.
    Kundu, Arunava
    Lietman, Thomas
    Whitcher, John P.
    Cunningham, Emmett T., Jr.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (05) : 570 - 575
  • [34] Autologous serum application in the treatment of Mooren's ulcer
    Mavrakanas, N. A.
    Kiel, R.
    Dosso, A. A.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (04) : 300 - 302
  • [35] Congenital corneal opacities in a cornea referral practice
    Rezende, RA
    Uchoa, UBC
    Uchoa, R
    Rapuano, CJ
    Laibson, PR
    Cohen, EJ
    CORNEA, 2004, 23 (06) : 565 - 570
  • [36] ETIOPATHOLOGICAL INVESTIGATION OF MOOREN ULCER
    ZHAO, JC
    JIN, XY
    CHINESE MEDICAL JOURNAL, 1993, 106 (01) : 57 - 60
  • [37] Mooren ulcer - An immunopathologic study
    Kafkala, Chrysanthi
    Choi, John
    Zafirakis, Panayotis
    Baltatzis, Stefanos
    Livir-Rallatos, Charalampos
    Rojas, Blanca
    Foster, C. Stephen
    CORNEA, 2006, 25 (06) : 667 - 673
  • [38] CYCLOSPORINE THERAPY IN MOOREN ULCER
    WAKEFIELD, D
    ROBINSON, LP
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1987, 71 (06) : 415 - 417
  • [39] Mooren's ulcer in China: a study of clinical characteristics and treatment
    Chen, JQ
    Xie, HP
    Wang, Z
    Yang, B
    Liu, ZG
    Chen, LS
    Gong, XM
    Lin, YS
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (11) : 1244 - 1249
  • [40] The Complete Success in Refractory Mooren's Ulcer Treated with Infliximab
    Cakmak, Ayse Idil
    Akova, Yonca
    Yildirim, Nilgun
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (04) : 682 - 688